Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Venclexta 100 MG Oral Tablet
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Venetoclax : 100mg on day 1, 200mg on day 2, 400mg on days 3 to 8; oral administration;
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Vonoprazan+amoxicillin+doxycycline+bismuth for 14 days
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
ZS801
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hemophilia B
1 trial -
anti-CD19/BCMA-UCAR-T cells
The First People's Hospital of Lianyungang
Rheumatoid Arthritis
1 trial -
anti-PD-1 / PD-L1 monoclonal antibody and chemotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Effect Increased
1 trial -
carotid-femoral pulse-wave velocity
Structure Therapeutics
Covid19
1 trial -
chemotherapy plus TCM 1&ICIs plusTCM2
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
cipher prescription 1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Percutaneous Coronary Artery Intervention
1 trial -
estradiol plus progesterone 100 mg IM injection
Universal Integrated
IVF
1 trial -
fludeoxyglucose F 18
United Therapeutics Europe Ltd
Lung Cancer
1 trial -
fludeoxyglucose F 18
United Therapeutics Europe Ltd
Testicular Germ Cell Tumor
1 trial -
insulin injection 15 minutes before meals
The First People's Hospital of Lianyungang
Diabetes
1 trial -
radiochemotherapy 1
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Non Small Cell Lung Cancer
1 trial -
standard-of-care imaging (18F-FDG, 68Ga-PSMA, or 68Ga-DOTATATE PET/CT), 68Ga-MY6349 PET/CT
The First People's Hospital of Lianyungang
Tumor
1 trial -
zanubrutinib 160 mg BID orally
The First People's Hospital of Lianyungang
Primary Central Nervous System Lymphoma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources